$MYG Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Mirati Therapeutics, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Mirati Therapeutics, Inc.. Get notifications about new insider transactions in Mirati Therapeutics, Inc. for free.
Page: < prev 1 2 3 4 5 6 next >
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 19 2019 | MYG | Mirati Therapeutic ... | LEMASTERS CHRISTOPHER C. | EVP, Chief Business ... | Sell | S | 71.65 | 41,438 | 2,968,966 | 18,562 | 60 K to 18.6 K (-69.06 %) |
| Feb 19 2019 | MYG | Mirati Therapeutic ... | LEMASTERS CHRISTOPHER C. | EVP, Chief Business ... | Buy | M | 6.45 | 60,000 | 387,000 | 60,000 | 0 to 60 K |
| Feb 13 2019 | MYG | Mirati Therapeutic ... | MVA Investors, LLC | 10% Owner | Sell | J | 0.00 | 18,955 | 0 | 494,675 | 513.6 K to 494.7 K (-3.69 %) |
| Jan 31 2019 | MYG | Mirati Therapeutic ... | Johnson Craig A | Option Exercise | M | 3.65 | 10,000 | 36,500 | 0 | ||
| Jan 31 2019 | MYG | Mirati Therapeutic ... | Johnson Craig A | Option Exercise | M | 15.79 | 7,000 | 110,530 | 0 | ||
| Jan 31 2019 | MYG | Mirati Therapeutic ... | Johnson Craig A | Sell | S | 61.80 | 8,525 | 526,831 | 0 | 8.5 K to 0 (-100.00 %) | |
| Jan 31 2019 | MYG | Mirati Therapeutic ... | Johnson Craig A | Sell | S | 61.11 | 8,475 | 517,941 | 8,525 | 17 K to 8.5 K (-49.85 %) | |
| Jan 31 2019 | MYG | Mirati Therapeutic ... | Johnson Craig A | Buy | M | 3.65 | 10,000 | 36,500 | 17,000 | 7 K to 17 K (+142.86 %) | |
| Jan 31 2019 | MYG | Mirati Therapeutic ... | Johnson Craig A | Buy | M | 15.79 | 7,000 | 110,530 | 7,000 | 0 to 7 K | |
| Jan 25 2019 | MYG | Mirati Therapeutic ... | CHEN ISAN | EVP, Chief Medical ... | Option Exercise | M | 5.40 | 1 | 5 | 49,997 | |
| Jan 25 2019 | MYG | Mirati Therapeutic ... | CHEN ISAN | EVP, Chief Medical ... | Option Exercise | M | 21.51 | 625 | 13,444 | 25,283 | |
| Jan 25 2019 | MYG | Mirati Therapeutic ... | CHEN ISAN | EVP, Chief Medical ... | Option Exercise | M | 24.99 | 244 | 6,098 | 59,756 | |
| Jan 25 2019 | MYG | Mirati Therapeutic ... | CHEN ISAN | EVP, Chief Medical ... | Buy | M | 5.40 | 1 | 5 | 35,836 | 35.8 K to 35.8 K (0.00 %) |
| Jan 25 2019 | MYG | Mirati Therapeutic ... | CHEN ISAN | EVP, Chief Medical ... | Buy | M | 21.51 | 625 | 13,444 | 35,835 | 35.2 K to 35.8 K (+1.78 %) |
| Jan 25 2019 | MYG | Mirati Therapeutic ... | CHEN ISAN | EVP, Chief Medical ... | Buy | M | 24.99 | 244 | 6,098 | 35,210 | 35 K to 35.2 K (+0.70 %) |
| Jan 22 2019 | MYG | Mirati Therapeutic ... | Davis Aaron I. | Option Exercise | A | 64.14 | 11,000 | 705,540 | 11,000 | ||
| Jan 22 2019 | MYG | Mirati Therapeutic ... | CHEN ISAN | EVP, Chief Medical ... | Option Exercise | A | 64.14 | 60,000 | 3,848,400 | 60,000 | |
| Jan 22 2019 | MYG | Mirati Therapeutic ... | LAPPE RODNEY W | Option Exercise | A | 64.14 | 11,000 | 705,540 | 11,000 | ||
| Jan 22 2019 | MYG | Mirati Therapeutic ... | Martinez Maria E | Option Exercise | A | 64.14 | 11,000 | 705,540 | 11,000 | ||
| Jan 22 2019 | MYG | Mirati Therapeutic ... | GREY MICHAEL G | Option Exercise | A | 64.14 | 11,000 | 705,540 | 11,000 | ||
| Jan 22 2019 | MYG | Mirati Therapeutic ... | FUCHS HENRY J | Option Exercise | A | 64.14 | 11,000 | 705,540 | 11,000 | ||
| Jan 22 2019 | MYG | Mirati Therapeutic ... | CARTER BRUCE L A | Option Exercise | A | 64.14 | 11,000 | 705,540 | 11,000 | ||
| Jan 22 2019 | MYG | Mirati Therapeutic ... | Johnson Craig A | Option Exercise | A | 64.14 | 11,000 | 705,540 | 11,000 | ||
| Jan 22 2019 | MYG | Mirati Therapeutic ... | LEMASTERS CHRISTOPHER C. | EVP, Chief Business ... | Option Exercise | A | 64.14 | 60,000 | 3,848,400 | 60,000 | |
| Jan 22 2019 | MYG | Mirati Therapeutic ... | Christensen Jamie | EVP, Chief Scientif ... | Option Exercise | A | 64.14 | 60,000 | 3,848,400 | 60,000 | |
| Jan 22 2019 | MYG | Mirati Therapeutic ... | Donadio Jamie A | Sr. VP, CFO | Option Exercise | A | 64.14 | 60,000 | 3,848,400 | 60,000 | |
| Jan 22 2019 | MYG | Mirati Therapeutic ... | BAUM CHARLES M | President & CEO | Option Exercise | A | 64.14 | 170,000 | 10,903,800 | 170,000 | |
| Jan 22 2019 | MYG | Mirati Therapeutic ... | Boxer Capital, LLC | 10% Owner | Buy | P | 62.00 | 150,000 | 9,300,000 | 1,715,560 | 1.6 M to 1.7 M (+9.58 %) |
| Jan 15 2019 | MYG | Mirati Therapeutic ... | Reisman Neil | 10% Owner | Option Exercise | M | 4.05 | 15,972 | 64,687 | 0 | |
| Jan 15 2019 | MYG | Mirati Therapeutic ... | Reisman Neil | 10% Owner | Option Exercise | M | 27.00 | 10,000 | 270,000 | 0 | |
| Jan 15 2019 | MYG | Mirati Therapeutic ... | Reisman Neil | 10% Owner | Payment of Exercise | F | 60.20 | 50 | 3,010 | 33,397 | 33.4 K to 33.4 K (-0.15 %) |
| Jan 15 2019 | MYG | Mirati Therapeutic ... | Reisman Neil | 10% Owner | Payment of Exercise | F | 59.50 | 5,656 | 336,532 | 33,447 | 39.1 K to 33.4 K (-14.46 %) |
| Jan 15 2019 | MYG | Mirati Therapeutic ... | Reisman Neil | 10% Owner | Buy | M | 4.05 | 15,972 | 64,687 | 39,103 | 23.1 K to 39.1 K (+69.05 %) |
| Jan 15 2019 | MYG | Mirati Therapeutic ... | Reisman Neil | 10% Owner | Buy | M | 27.00 | 10,000 | 270,000 | 23,131 | 13.1 K to 23.1 K (+76.16 %) |
| Jan 15 2019 | MYG | Mirati Therapeutic ... | Reisman Neil | 10% Owner | Option Exercise | M | 4.05 | 15,972 | 64,687 | 0 | |
| Jan 15 2019 | MYG | Mirati Therapeutic ... | Reisman Neil | 10% Owner | Option Exercise | M | 27.00 | 10,000 | 270,000 | 0 | |
| Jan 15 2019 | MYG | Mirati Therapeutic ... | Reisman Neil | 10% Owner | Payment of Exercise | F | 60.20 | 50 | 3,010 | 33,397 | 33.4 K to 33.4 K (-0.15 %) |
| Jan 15 2019 | MYG | Mirati Therapeutic ... | Reisman Neil | 10% Owner | Payment of Exercise | F | 59.50 | 5,656 | 336,532 | 33,447 | 39.1 K to 33.4 K (-14.46 %) |
| Jan 15 2019 | MYG | Mirati Therapeutic ... | Reisman Neil | 10% Owner | Buy | M | 4.05 | 15,972 | 64,687 | 39,103 | 23.1 K to 39.1 K (+69.05 %) |
| Jan 15 2019 | MYG | Mirati Therapeutic ... | Reisman Neil | 10% Owner | Buy | M | 27.00 | 10,000 | 270,000 | 23,131 | 13.1 K to 23.1 K (+76.16 %) |
| Jan 09 2019 | MYG | Mirati Therapeutic ... | Davis Aaron I. | Director | Sell | S | 53.40 | 5,000 | 267,000 | 37,052 | 42.1 K to 37.1 K (-11.89 %) |
| Jan 09 2019 | MYG | Mirati Therapeutic ... | Davis Aaron I. | Director | Sell | S | 52.20 | 5,000 | 261,000 | 42,052 | 47.1 K to 42.1 K (-10.63 %) |
| Jan 09 2019 | MYG | Mirati Therapeutic ... | Davis Aaron I. | Director | Sell | S | 47.48 | 15,000 | 712,200 | 47,052 | 62.1 K to 47.1 K (-24.17 %) |
| Jan 09 2019 | MYG | Mirati Therapeutic ... | Davis Aaron I. | Director | Sell | S | 46.29 | 8,357 | 386,846 | 62,052 | 70.4 K to 62.1 K (-11.87 %) |
| Jan 09 2019 | MYG | Mirati Therapeutic ... | Davis Aaron I. | Director | Sell | S | 45.47 | 16,643 | 756,757 | 70,409 | 87.1 K to 70.4 K (-19.12 %) |
| Jan 09 2019 | MYG | Mirati Therapeutic ... | Boxer Capital, LLC | 10% Owner | Option Exercise | M | 0.00 | 150,003 | 150 | 1,641,771 | |
| Jan 09 2019 | MYG | Mirati Therapeutic ... | Boxer Capital, LLC | 10% Owner | Option Exercise | M | 0.00 | 550,012 | 550 | 1,791,774 | |
| Jan 09 2019 | MYG | Mirati Therapeutic ... | Boxer Capital, LLC | 10% Owner | Buy | M | 0.00 | 150,003 | 150 | 1,565,560 | 1.4 M to 1.6 M (+10.60 %) |
| Jan 09 2019 | MYG | Mirati Therapeutic ... | Boxer Capital, LLC | 10% Owner | Payment of Exercise | F | 50.89 | 3 | 153 | 1,415,557 | 1.4 M to 1.4 M (0.00 %) |
| Jan 09 2019 | MYG | Mirati Therapeutic ... | Boxer Capital, LLC | 10% Owner | Sell | S | 52.27 | 50,000 | 2,613,500 | 1,415,560 | 1.5 M to 1.4 M (-3.41 %) |
| Jan 09 2019 | MYG | Mirati Therapeutic ... | Boxer Capital, LLC | 10% Owner | Sell | S | 51.43 | 80,000 | 4,114,400 | 1,465,560 | 1.5 M to 1.5 M (-5.18 %) |
| Jan 09 2019 | MYG | Mirati Therapeutic ... | Boxer Capital, LLC | 10% Owner | Sell | S | 50.21 | 20,000 | 1,004,200 | 1,545,560 | 1.6 M to 1.5 M (-1.28 %) |
| Jan 09 2019 | MYG | Mirati Therapeutic ... | Boxer Capital, LLC | 10% Owner | Buy | M | 0.00 | 550,012 | 550 | 1,565,560 | 1 M to 1.6 M (+54.16 %) |
| Jan 09 2019 | MYG | Mirati Therapeutic ... | Boxer Capital, LLC | 10% Owner | Payment of Exercise | F | 48.28 | 12 | 579 | 1,015,548 | 1 M to 1 M (0.00 %) |
| Jan 09 2019 | MYG | Mirati Therapeutic ... | Boxer Capital, LLC | 10% Owner | Sell | S | 54.36 | 42,897 | 2,331,881 | 1,015,560 | 1.1 M to 1 M (-4.05 %) |
| Jan 09 2019 | MYG | Mirati Therapeutic ... | Boxer Capital, LLC | 10% Owner | Sell | S | 52.88 | 233,303 | 12,337,063 | 1,058,457 | 1.3 M to 1.1 M (-18.06 %) |
| Jan 09 2019 | MYG | Mirati Therapeutic ... | Boxer Capital, LLC | 10% Owner | Sell | S | 51.56 | 123,800 | 6,383,128 | 1,291,760 | 1.4 M to 1.3 M (-8.75 %) |
| Jan 09 2019 | MYG | Mirati Therapeutic ... | Boxer Capital, LLC | 10% Owner | Sell | S | 50.70 | 150,000 | 7,605,000 | 1,415,560 | 1.6 M to 1.4 M (-9.58 %) |
| Jan 09 2019 | MYG | Mirati Therapeutic ... | Davis Aaron I. | Director | Sell | S | 53.40 | 5,000 | 267,000 | 37,052 | 42.1 K to 37.1 K (-11.89 %) |
| Jan 09 2019 | MYG | Mirati Therapeutic ... | Davis Aaron I. | Director | Sell | S | 52.20 | 5,000 | 261,000 | 42,052 | 47.1 K to 42.1 K (-10.63 %) |
| Jan 09 2019 | MYG | Mirati Therapeutic ... | Davis Aaron I. | Director | Sell | S | 47.48 | 15,000 | 712,200 | 47,052 | 62.1 K to 47.1 K (-24.17 %) |
| Jan 09 2019 | MYG | Mirati Therapeutic ... | Davis Aaron I. | Director | Sell | S | 46.29 | 8,357 | 386,846 | 62,052 | 70.4 K to 62.1 K (-11.87 %) |
| Jan 09 2019 | MYG | Mirati Therapeutic ... | Davis Aaron I. | Director | Sell | S | 45.47 | 16,643 | 756,757 | 70,409 | 87.1 K to 70.4 K (-19.12 %) |
| Jan 09 2019 | MYG | Mirati Therapeutic ... | Boxer Capital, LLC | 10% Owner | Option Exercise | M | 0.00 | 150,003 | 150 | 1,641,771 | |
| Jan 09 2019 | MYG | Mirati Therapeutic ... | Boxer Capital, LLC | 10% Owner | Option Exercise | M | 0.00 | 550,012 | 550 | 1,791,774 | |
| Jan 09 2019 | MYG | Mirati Therapeutic ... | Boxer Capital, LLC | 10% Owner | Buy | M | 0.00 | 150,003 | 150 | 1,565,560 | 1.4 M to 1.6 M (+10.60 %) |
| Jan 09 2019 | MYG | Mirati Therapeutic ... | Boxer Capital, LLC | 10% Owner | Payment of Exercise | F | 50.89 | 3 | 153 | 1,415,557 | 1.4 M to 1.4 M (0.00 %) |
| Jan 09 2019 | MYG | Mirati Therapeutic ... | Boxer Capital, LLC | 10% Owner | Sell | S | 52.27 | 50,000 | 2,613,500 | 1,415,560 | 1.5 M to 1.4 M (-3.41 %) |
| Jan 09 2019 | MYG | Mirati Therapeutic ... | Boxer Capital, LLC | 10% Owner | Sell | S | 51.43 | 80,000 | 4,114,400 | 1,465,560 | 1.5 M to 1.5 M (-5.18 %) |
| Jan 09 2019 | MYG | Mirati Therapeutic ... | Boxer Capital, LLC | 10% Owner | Sell | S | 50.21 | 20,000 | 1,004,200 | 1,545,560 | 1.6 M to 1.5 M (-1.28 %) |
| Jan 09 2019 | MYG | Mirati Therapeutic ... | Boxer Capital, LLC | 10% Owner | Buy | M | 0.00 | 550,012 | 550 | 1,565,560 | 1 M to 1.6 M (+54.16 %) |
| Jan 09 2019 | MYG | Mirati Therapeutic ... | Boxer Capital, LLC | 10% Owner | Payment of Exercise | F | 48.28 | 12 | 579 | 1,015,548 | 1 M to 1 M (0.00 %) |
| Jan 09 2019 | MYG | Mirati Therapeutic ... | Boxer Capital, LLC | 10% Owner | Sell | S | 54.36 | 42,897 | 2,331,881 | 1,015,560 | 1.1 M to 1 M (-4.05 %) |
| Jan 09 2019 | MYG | Mirati Therapeutic ... | Boxer Capital, LLC | 10% Owner | Sell | S | 52.88 | 233,303 | 12,337,063 | 1,058,457 | 1.3 M to 1.1 M (-18.06 %) |
| Jan 09 2019 | MYG | Mirati Therapeutic ... | Boxer Capital, LLC | 10% Owner | Sell | S | 51.56 | 123,800 | 6,383,128 | 1,291,760 | 1.4 M to 1.3 M (-8.75 %) |
| Jan 09 2019 | MYG | Mirati Therapeutic ... | Boxer Capital, LLC | 10% Owner | Sell | S | 50.70 | 150,000 | 7,605,000 | 1,415,560 | 1.6 M to 1.4 M (-9.58 %) |
| Dec 28 2018 | MYG | Mirati Therapeutic ... | Christensen Jamie | EVP, Chief Scientif ... | Option Exercise | M | 17.41 | 5,169 | 89,992 | 13,767 | |
| Dec 28 2018 | MYG | Mirati Therapeutic ... | Christensen Jamie | EVP, Chief Scientif ... | Buy | M | 17.41 | 5,169 | 89,992 | 8,789 | 3.6 K to 8.8 K (+142.79 %) |
| Dec 13 2018 | MYG | Mirati Therapeutic ... | Martinez Maria E | Option Exercise | A | 39.76 | 25,000 | 994,000 | 25,000 | ||
| Dec 10 2018 | MYG | Mirati Therapeutic ... | Davis Aaron I. | Option Exercise | A | 39.76 | 25,000 | 994,000 | 25,000 | ||
| Dec 10 2018 | MYG | Mirati Therapeutic ... | Christensen Jamie | EVP, Chief Scientif ... | Option Exercise | A | 39.76 | 30,000 | 1,192,800 | 30,000 | |
| Aug 24 2018 | MYG | Mirati Therapeutic ... | BAUM CHARLES M | President & CEO | Option Exercise | M | 17.41 | 11,486 | 199,971 | 138,514 | |
| Aug 24 2018 | MYG | Mirati Therapeutic ... | BAUM CHARLES M | President & CEO | Option Exercise | M | 8.50 | 51,810 | 440,385 | 103,620 | |
| Aug 24 2018 | MYG | Mirati Therapeutic ... | BAUM CHARLES M | President & CEO | Buy | M | 17.41 | 11,486 | 199,971 | 62,418 | 50.9 K to 62.4 K (+22.55 %) |
| Aug 24 2018 | MYG | Mirati Therapeutic ... | BAUM CHARLES M | President & CEO | Sell | S | 58.40 | 1,862 | 108,734 | 50,932 | 52.8 K to 50.9 K (-3.53 %) |
| Aug 24 2018 | MYG | Mirati Therapeutic ... | BAUM CHARLES M | President & CEO | Sell | S | 57.86 | 32,514 | 1,881,325 | 52,794 | 85.3 K to 52.8 K (-38.11 %) |
| Aug 24 2018 | MYG | Mirati Therapeutic ... | BAUM CHARLES M | President & CEO | Sell | S | 56.88 | 17,434 | 991,730 | 85,308 | 102.7 K to 85.3 K (-16.97 %) |
| Aug 24 2018 | MYG | Mirati Therapeutic ... | BAUM CHARLES M | President & CEO | Buy | M | 8.50 | 51,810 | 440,385 | 102,742 | 50.9 K to 102.7 K (+101.72 %) |
| Jul 17 2018 | MYG | Mirati Therapeutic ... | CHEN ISAN | EVP, Chief Medical ... | Option Exercise | M | 21.51 | 1,592 | 34,244 | 25,908 | |
| Jul 17 2018 | MYG | Mirati Therapeutic ... | CHEN ISAN | EVP, Chief Medical ... | Option Exercise | M | 17.41 | 275 | 4,788 | 5,913 | |
| Jul 17 2018 | MYG | Mirati Therapeutic ... | CHEN ISAN | EVP, Chief Medical ... | Buy | M | 21.51 | 1,592 | 34,244 | 34,582 | 33 K to 34.6 K (+4.83 %) |
| Jul 17 2018 | MYG | Mirati Therapeutic ... | CHEN ISAN | EVP, Chief Medical ... | Buy | M | 17.41 | 275 | 4,788 | 32,111 | 31.8 K to 32.1 K (+0.86 %) |
| Jun 28 2018 | MYG | Mirati Therapeutic ... | Christensen Jamie | SVP, Chief Scientif ... | Option Exercise | M | 5.50 | 4,999 | 27,495 | 17,502 | |
| Jun 28 2018 | MYG | Mirati Therapeutic ... | Christensen Jamie | SVP, Chief Scientif ... | Option Exercise | M | 5.40 | 5,208 | 28,123 | 32,292 | |
| Jun 28 2018 | MYG | Mirati Therapeutic ... | Christensen Jamie | SVP, Chief Scientif ... | Sell | S | 51.33 | 29 | 1,488 | 3,394 | 3.4 K to 3.4 K (-0.85 %) |
| Jun 28 2018 | MYG | Mirati Therapeutic ... | Christensen Jamie | SVP, Chief Scientif ... | Sell | S | 50.15 | 736 | 36,910 | 3,423 | 4.2 K to 3.4 K (-17.70 %) |
| Jun 28 2018 | MYG | Mirati Therapeutic ... | Christensen Jamie | SVP, Chief Scientif ... | Sell | S | 49.43 | 4,234 | 209,266 | 4,159 | 8.4 K to 4.2 K (-50.45 %) |
| Jun 28 2018 | MYG | Mirati Therapeutic ... | Christensen Jamie | SVP, Chief Scientif ... | Buy | M | 5.50 | 4,999 | 27,495 | 8,393 | 3.4 K to 8.4 K (+147.29 %) |
| Jun 28 2018 | MYG | Mirati Therapeutic ... | Christensen Jamie | SVP, Chief Scientif ... | Sell | S | 49.27 | 1,150 | 56,658 | 3,394 | 4.5 K to 3.4 K (-25.31 %) |
| Jun 28 2018 | MYG | Mirati Therapeutic ... | Christensen Jamie | SVP, Chief Scientif ... | Sell | S | 48.62 | 4,058 | 197,307 | 4,027 | 8.1 K to 4 K (-50.19 %) |
| Jun 28 2018 | MYG | Mirati Therapeutic ... | Christensen Jamie | SVP, Chief Scientif ... | Buy | M | 5.40 | 5,208 | 28,123 | 8,085 | 2.9 K to 8.1 K (+181.02 %) |
| Jun 12 2018 | MYG | Mirati Therapeutic ... | venBio Select Advisor LLC | 10% Owner | Option Exercise | P | 0.00 | 63,235 | 63 | 63,235 | |
| Jun 12 2018 | MYG | Mirati Therapeutic ... | venBio Select Advisor LLC | 10% Owner | Buy | P | 38.85 | 400,000 | 15,540,000 | 4,798,101 | 4.4 M to 4.8 M (+9.09 %) |
| Jun 11 2018 | MYG | Mirati Therapeutic ... | Boxer Capital, LLC | 10% Owner | Buy | P | 38.85 | 193,050 | 7,499,993 | 1,565,560 | 1.4 M to 1.6 M (+14.07 %) |
| Apr 26 2018 | MYG | Mirati Therapeutic ... | CHEN ISAN | EVP, Chief Medical ... | Option Exercise | M | 21.51 | 2,500 | 53,775 | 27,500 | |
| Apr 26 2018 | MYG | Mirati Therapeutic ... | CHEN ISAN | EVP, Chief Medical ... | Option Exercise | M | 17.41 | 412 | 7,173 | 6,188 | |
| Apr 26 2018 | MYG | Mirati Therapeutic ... | CHEN ISAN | EVP, Chief Medical ... | Option Exercise | M | 15.79 | 10,124 | 159,858 | 96,668 | |
| Apr 26 2018 | MYG | Mirati Therapeutic ... | CHEN ISAN | EVP, Chief Medical ... | Option Exercise | M | 5.40 | 2 | 11 | 49,998 | |
| Apr 26 2018 | MYG | Mirati Therapeutic ... | CHEN ISAN | EVP, Chief Medical ... | Buy | M | 21.51 | 2,500 | 53,775 | 31,836 | 29.3 K to 31.8 K (+8.52 %) |
| Apr 26 2018 | MYG | Mirati Therapeutic ... | CHEN ISAN | EVP, Chief Medical ... | Buy | M | 17.41 | 412 | 7,173 | 29,336 | 28.9 K to 29.3 K (+1.42 %) |
| Apr 26 2018 | MYG | Mirati Therapeutic ... | CHEN ISAN | EVP, Chief Medical ... | Buy | M | 15.79 | 10,124 | 159,858 | 28,924 | 18.8 K to 28.9 K (+53.85 %) |
| Apr 26 2018 | MYG | Mirati Therapeutic ... | CHEN ISAN | EVP, Chief Medical ... | Buy | M | 5.40 | 2 | 11 | 18,800 | 18.8 K to 18.8 K (+0.01 %) |
| Apr 26 2018 | MYG | Mirati Therapeutic ... | Christensen Jamie | SVP, Chief Scientif ... | Option Exercise | M | 24.99 | 7,500 | 187,425 | 45,000 | |
| Apr 26 2018 | MYG | Mirati Therapeutic ... | Christensen Jamie | SVP, Chief Scientif ... | Option Exercise | M | 21.51 | 7,500 | 161,325 | 15,000 | |
| Apr 26 2018 | MYG | Mirati Therapeutic ... | Christensen Jamie | SVP, Chief Scientif ... | Option Exercise | M | 17.41 | 7,000 | 121,870 | 18,936 | |
| Apr 26 2018 | MYG | Mirati Therapeutic ... | Christensen Jamie | SVP, Chief Scientif ... | Sell | S | 33.00 | 22,000 | 726,040 | 2,877 | 24.9 K to 2.9 K (-88.44 %) |
| Apr 26 2018 | MYG | Mirati Therapeutic ... | Christensen Jamie | SVP, Chief Scientif ... | Buy | M | 24.99 | 7,500 | 187,425 | 24,877 | 17.4 K to 24.9 K (+43.16 %) |
| Apr 26 2018 | MYG | Mirati Therapeutic ... | Christensen Jamie | SVP, Chief Scientif ... | Buy | M | 21.51 | 7,500 | 161,325 | 17,377 | 9.9 K to 17.4 K (+75.93 %) |
| Apr 26 2018 | MYG | Mirati Therapeutic ... | Christensen Jamie | SVP, Chief Scientif ... | Buy | M | 17.41 | 7,000 | 121,870 | 9,877 | 2.9 K to 9.9 K (+243.31 %) |
| Mar 13 2018 | MYG | Mirati Therapeutic ... | Donadio Jamie A | Sr. VP, CFO | Option Exercise | M | 17.41 | 12,100 | 210,661 | 1,100 | |
| Mar 13 2018 | MYG | Mirati Therapeutic ... | Donadio Jamie A | Sr. VP, CFO | Sell | S | 35.00 | 12,100 | 423,500 | 0 | 12.1 K to 0 (-100.00 %) |
| Mar 13 2018 | MYG | Mirati Therapeutic ... | Donadio Jamie A | Sr. VP, CFO | Buy | M | 17.41 | 12,100 | 210,661 | 12,100 | 0 to 12.1 K |
| Mar 02 2018 | MYG | Mirati Therapeutic ... | Donadio Jamie A | Sr. VP, CFO | Option Exercise | M | 7.30 | 30,000 | 219,000 | 0 | |
| Mar 02 2018 | MYG | Mirati Therapeutic ... | Donadio Jamie A | Sr. VP, CFO | Option Exercise | M | 5.40 | 12,500 | 67,500 | 37,500 | |
| Mar 02 2018 | MYG | Mirati Therapeutic ... | Donadio Jamie A | Sr. VP, CFO | Option Exercise | M | 5.50 | 9,375 | 51,563 | 20,625 | |
| Mar 02 2018 | MYG | Mirati Therapeutic ... | Donadio Jamie A | Sr. VP, CFO | Sell | S | 28.08 | 500 | 14,040 | 0 | 500 to 0 (-100.00 %) |
| Mar 02 2018 | MYG | Mirati Therapeutic ... | Donadio Jamie A | Sr. VP, CFO | Sell | S | 27.45 | 25,775 | 707,591 | 500 | 26.3 K to 500 (-98.10 %) |
| Mar 02 2018 | MYG | Mirati Therapeutic ... | Donadio Jamie A | Sr. VP, CFO | Sell | S | 26.78 | 25,600 | 685,514 | 26,275 | 51.9 K to 26.3 K (-49.35 %) |
| Mar 02 2018 | MYG | Mirati Therapeutic ... | Donadio Jamie A | Sr. VP, CFO | Buy | M | 7.30 | 30,000 | 219,000 | 51,875 | 21.9 K to 51.9 K (+137.14 %) |
| Mar 02 2018 | MYG | Mirati Therapeutic ... | Donadio Jamie A | Sr. VP, CFO | Buy | M | 5.40 | 12,500 | 67,500 | 21,875 | 9.4 K to 21.9 K (+133.33 %) |
| Mar 02 2018 | MYG | Mirati Therapeutic ... | Donadio Jamie A | Sr. VP, CFO | Buy | M | 5.50 | 9,375 | 51,563 | 9,375 | 0 to 9.4 K |
| Feb 08 2018 | MYG | Mirati Therapeutic ... | Christensen Jamie | SVP, Chief Scientif ... | Option Exercise | M | 21.51 | 7,500 | 161,325 | 22,500 | |
| Feb 08 2018 | MYG | Mirati Therapeutic ... | Christensen Jamie | SVP, Chief Scientif ... | Option Exercise | M | 24.99 | 7,500 | 187,425 | 52,500 | |
| Feb 08 2018 | MYG | Mirati Therapeutic ... | Christensen Jamie | SVP, Chief Scientif ... | Option Exercise | M | 17.41 | 8,000 | 139,280 | 25,936 | |
| Feb 08 2018 | MYG | Mirati Therapeutic ... | Christensen Jamie | SVP, Chief Scientif ... | Sell | S | 30.00 | 23,000 | 690,000 | 2,877 | 25.9 K to 2.9 K (-88.88 %) |
| Feb 08 2018 | MYG | Mirati Therapeutic ... | Christensen Jamie | SVP, Chief Scientif ... | Buy | M | 21.51 | 7,500 | 161,325 | 25,877 | 18.4 K to 25.9 K (+40.81 %) |
| Feb 08 2018 | MYG | Mirati Therapeutic ... | Christensen Jamie | SVP, Chief Scientif ... | Buy | M | 24.99 | 7,500 | 187,425 | 18,377 | 10.9 K to 18.4 K (+68.95 %) |
| Feb 08 2018 | MYG | Mirati Therapeutic ... | Christensen Jamie | SVP, Chief Scientif ... | Buy | M | 17.41 | 8,000 | 139,280 | 10,877 | 2.9 K to 10.9 K (+278.07 %) |
| Jan 29 2018 | MYG | Mirati Therapeutic ... | Christensen Jamie | SVP, Chief Scientif ... | Option Exercise | M | 5.40 | 12,500 | 67,500 | 37,500 | |
| Jan 29 2018 | MYG | Mirati Therapeutic ... | Christensen Jamie | SVP, Chief Scientif ... | Sell | S | 26.11 | 12,500 | 326,423 | 2,877 | 15.4 K to 2.9 K (-81.29 %) |
| Jan 29 2018 | MYG | Mirati Therapeutic ... | Christensen Jamie | SVP, Chief Scientif ... | Buy | M | 5.40 | 12,500 | 67,500 | 15,377 | 2.9 K to 15.4 K (+434.48 %) |
| Jan 22 2018 | MYG | Mirati Therapeutic ... | LAPPE RODNEY W | Option Exercise | A | 27.00 | 15,000 | 405,000 | 15,000 | ||
| Jan 22 2018 | MYG | Mirati Therapeutic ... | CARTER BRUCE L A | Option Exercise | A | 27.00 | 10,000 | 270,000 | 10,000 | ||
| Jan 22 2018 | MYG | Mirati Therapeutic ... | GREY MICHAEL G | Option Exercise | A | 27.00 | 10,000 | 270,000 | 10,000 | ||
| Jan 22 2018 | MYG | Mirati Therapeutic ... | FUCHS HENRY J | Option Exercise | A | 27.00 | 10,000 | 270,000 | 10,000 | ||
| Jan 22 2018 | MYG | Mirati Therapeutic ... | Johnson Craig A | Option Exercise | A | 27.00 | 10,000 | 270,000 | 10,000 | ||
| Jan 22 2018 | MYG | Mirati Therapeutic ... | BAUM CHARLES M | President & CEO | Option Exercise | A | 27.00 | 185,000 | 4,995,000 | 185,000 | |
| Jan 22 2018 | MYG | Mirati Therapeutic ... | LEMASTERS CHRISTOPHER C. | EVP, Chief Business ... | Option Exercise | A | 27.00 | 65,000 | 1,755,000 | 65,000 | |
| Jan 22 2018 | MYG | Mirati Therapeutic ... | Donadio Jamie A | Sr. VP, CFO | Option Exercise | A | 27.00 | 50,000 | 1,350,000 | 50,000 | |
| Jan 22 2018 | MYG | Mirati Therapeutic ... | Christensen Jamie | SVP, Chief Scientif ... | Option Exercise | A | 27.00 | 80,000 | 2,160,000 | 80,000 |